Dexcom (DXCM)

Dexcom (DXCM) Stock Price & Analysis


DXCM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$66.89 - $134.77
Previous Close$118.98
Average Volume (3M)2.51M
Market Cap
Enterprise Value$45.66B
Total Cash (Recent Filing)$2.46B
Total Debt (Recent Filing)$2.15B
Price to Earnings (P/E)145.5
May 03, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.82
Shares Outstanding386,413,690
10 Day Avg. Volume2,644,445
30 Day Avg. Volume2,512,200
Standard Deviation0.16
Financial Highlights & Ratios
Price to Book (P/B)22.94
Price to Sales (P/S)15.24
Price to Cash Flow (P/CF)73.30
P/FCF Ratio147.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue15.69
Enterprise Value/Gross Profit24.25
Enterprise Value/Ebitda80.66
Price Target Upside10.46% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Dexcom’s price range in the past 12 months?
Dexcom lowest stock price was $66.89 and its highest was $134.76 in the past 12 months.
    What is Dexcom’s market cap?
    Currently, no data Available
    When is Dexcom’s upcoming earnings report date?
    Dexcom’s upcoming earnings report date is May 03, 2023 which is in 42 days.
      How were Dexcom’s earnings last quarter?
      Dexcom released its earnings results on Feb 09, 2023. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.273 by $0.067.
        Is Dexcom overvalued?
        According to Wall Street analysts Dexcom’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Dexcom pay dividends?
          Dexcom does not currently pay dividends.
          What is Dexcom’s EPS estimate?
          Dexcom’s EPS estimate is $0.15.
            How many shares outstanding does Dexcom have?
            Dexcom has 386,413,700 shares outstanding.
              What happened to Dexcom’s price movement after its last earnings report?
              Dexcom reported an EPS of $0.34 in its last earnings report, beating expectations of $0.273. Following the earnings report the stock price went up 9.931%.
                Which hedge fund is a major shareholder of Dexcom?
                Among the largest hedge funds holding Dexcom’s share is Sands Capital Management LLC. It holds Dexcom’s shares valued at 2B.


                  Dexcom Stock Smart Score

                  The Dexcom stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  California-based DexCom, Inc. is a medical device manufacturing company. The company designs, develops and focuses on commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes. Its products include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom Share.


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Intuitive Surgical
                  Becton Dickinson
                  Boston Scientific
                  Edwards Lifesciences

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis